Co-Authors
This is a "connection" page, showing publications co-authored by Justin Stebbing and Andre Kalil.
Connection Strength
0.965
-
Baricitinib: the first immunomodulatory treatment to reduce COVID-19 mortality in a placebo-controlled trial. Lancet Respir Med. 2021 12; 9(12):1349-1351.
Score: 0.965
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.